Fride Pharma Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Fride Pharma General Information
Description
Developer of drugs designed to bring effective treatments for tourette's syndrome and schizophrenia. The company offers novel drugs that have botanical compounds, orally available, not derived from cannabis, approved for human use, effective as pain relievers, anti-inflammatories, and anxiolytics, enabling healthcare professionals to access innovative therapies, improving patient outcomes and quality of life.
Contact Information
Website
www.fridepharma.comCorporate Office
- 19 Bon-Accord Crescent
- Aberdeen AB11 6DE
- Scotland, United Kingdom
Corporate Office
- 19 Bon-Accord Crescent
- Aberdeen AB11 6DE
- Scotland, United Kingdom
Fride Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 20-May-2025 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue |
Fride Pharma FAQs
-
When was Fride Pharma founded?
Fride Pharma was founded in 2020.
-
Where is Fride Pharma headquartered?
Fride Pharma is headquartered in Aberdeen, United Kingdom.
-
What industry is Fride Pharma in?
Fride Pharma’s primary industry is Drug Discovery.
-
Is Fride Pharma a private or public company?
Fride Pharma is a Private company.
-
What is Fride Pharma’s current revenue?
The current revenue for Fride Pharma is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process